The AUROC showed FCI (44%) to have a significantly lower sensitivity when compared with FIB-4 (58%), APRI (57%), AST/ALT (61%), age-platelet (60%), and FI (58%) in detecting liver fibrosis for all diagnoses (Figure 2). The gene discussed is GPT; the disease is Hepatic fibrosis.